Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Understanding what a beginner investment portfolio looks like is crucial for new investors. Learn the basics to kickstart your investment journey.
27,003 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A rapid Trump-backed rally has pushed stocks to fresh highs, yet selective bargains remain. The market shows pockets ...
A new market dynamic is taking hold: memory pricing and capex discipline are steering the current semiconductor upcyc...
Policy clarity cleared a Senate hurdle, but bitcoin demand weakens despite the CLARITY Act win as ETF buyers pull bac...
Bitcoin and gold ETFs have faced two weeks of net outflows, signaling a cooling of the debasement trade as investors ...
Bitcoin slumped sharply while major altcoins fell, erasing about $150 billion from crypto markets and stirring a fres...
A monthly dividend growth fund has outperformed SCHD by 38 percentage points over the past decade, challenging the tr...
SpaceX's blockbuster IPO has turned volatile as market conditions cool on AI and space tech bets. The stock has retre...
A year after taking the helm at Stellantis, Antonio Filosa faces a mixed bag: a Q1 2026 earnings beat, a historic 202...
Iran tensions could ripple through travel, housing and markets beyond fuel costs. Analysts warn that higher prices ar...
Chip stocks slipped as SK Hynix flagged weaker memory demand and a jump in oil prices threatened chip margins. The tr...
Bitcoin trades in the mid-$60,000s after a major unwind of leveraged bets. Analysts say institutional demand could st...